Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

38
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ALLERGAN, INC.
2h ago ALLERGAN : David Pyott Recognized by Harvard Business Review
4d ago ACKMAN : Lawyers have documents purported to show Allergan misled on Valeant
4d ago AbbVie board ditches planned $55 billion Shire acquisition
5d ago ALLERGAN : Patent Issued for Ester Pro-Drugs of Methanol for Treating Retinal Di..
5d ago ALLERGAN : Patent Issued for Polysaccharide Gel Formulation Having Increased Lon..
5d ago ALLERGAN : Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in th..
6d ago Irish tax changes may cost U.S. groups billions
6d ago ALLERGAN : Dr. Rami Batniji Selected By Allergan To Test Their Total Facial Reju..
6d ago ALLERGAN : Offers Details of Earnings Per Share and Sales Expectations
7d ago ALLERGAN : Pershing Square debuts on Euronext Amsterdam
10/13 Activist investor Ackman's fund Pershing dips on Amsterdam debut
10/10 EXCLUSIVE - TOP ACTAVIS HOLDER, FIDE : sources
10/09 Allergan raises outlook; says Valeant offer undervalues company
10/09 ALLERGAN : Results of Operations and Financial Condition, Financial Statements a..
10/09 ALLERGAN : Provides Update on Earnings Per Share and Sales Expectations
10/09DJU.S. HOT STOCKS : Hot Stocks to Watch
10/08 ALLERGAN : Patent Issued for Targeted Delivery of Botulinum Toxin to the Sphenop..
10/08 ALLERGAN : Announces FDA Approves Revised Indication for OZURDEX® dexamethasone ..
10/08 ALLERGAN : Actavis plans Allergan offer
10/07 EXCLUSIVE : Actavis plans new merger approach for Allergan - sources
10/07 EXCLUSIVE - ACTAVIS PLANS NEW MERGER : sources
10/04 ALLERGAN : Assigned Patent
10/03 ALLERGAN : Researchers Submit Patent Application, "Composition of a Sustained-Re..
10/03 ALLERGAN : Researchers Submit Patent Application, "Prostanoid Receptor Agonist C..
10/03 ALLERGAN : Patent Application Titled "Compositions Including Encapsulated Isotre..
10/03 ALLERGAN : "Prostamides for Enhancement of Leptin Production" in Patent Applicat..
10/03 ALLERGAN : Researchers Submit Patent Application, "Inhibition of Neovascularizat..
10/03 ALLERGAN : Researchers Submit Patent Application, "Inhibition of Neovascularizat..
10/02 ALLERGAN : Assigned Patent
10/01 ALLERGAN : Ackman's Pershing Square raises $3 bln in fund listing
09/29 ALLERGAN : Valeant Pharmaceuticals' third-quarter sales to rise
09/29 ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
09/29 ALLERGAN : Announces FDA Approves Revised Indication for OZURDEX® (dexamethasone..
09/29 ALLERGAN : Board of Directors Issues Statement
09/28 ALLERGAN : Plastic Surgery Practice in Naples Awarded Allergan's Diamond Status
09/25 TSX tumbles to three-month low as sentiment sours
09/25 ALLERGAN : Issues Statement Regarding Recent Valeant Correspondence
09/25 ALLERGAN : Valeant pitches potential eye drug, research focus
09/24 ALLERGAN : Pershing Square, Valeant and Allergan Settle Pending Litigation Befor..
09/24 ALLERGAN : Patent Issued for Computer Analysis of a Breast Shape to Assist Breas..
09/24 ALLERGAN : "Ophthalmic Compositions and Methods for Treating Eyes" in Patent App..
09/24 ALLERGAN : to Hold Special Meeting of Stockholders on Originally Scheduled Date ..
09/24 ALLERGAN : Patent Issued for Compounds Having Analgesic And/Or Immunostimulant A..
09/24 ALLERGAN : Patent Application Titled "Preservative Free Bimatoprost and Timolol ..
09/24 ALLERGAN : Actress And TV Star Kyle Richards Diagnosed With A Type Of Chronic Dr..
09/24 S&P 500 MOVERS : Btu, bbby
09/24 ALLERGAN : Valeant Pharma expects 3Q revenue to top forecasts
09/24 Valeant CEO expects quarterly profit to exceed forecast
09/24 ACTAVIS IN BUYOUT TALKS WITH SALIX : Cnbc
09/24 ALLERGAN : Valeant Provides Update On Third Quarter Results And Sends Letter To ..
09/24 ALLERGAN : Assigned Patent
09/23 ALLERGAN : Write-Offs: 09.22.14
09/18 ALLERGAN : Actress And Tv Star Kyle Richards Diagnosed With A Type Of Chronic Dr..
09/18 ALLERGAN : to cut its workforce by 13%
09/18 ALLERGAN : Assigned Patent
09/17 ALLERGAN : Researchers Submit Patent Application, "Extended Release Biodegradabl..
09/17 ALLERGAN : Patent Application Titled "Compounds Act at Multiple Prostaglandin Re..
09/16 ALLERGAN : reaches truce with suitors on special shareholder meeting
09/16DJU.S. HOT STOCKS : Hot Stocks to Watch
09/16 ALLERGAN : agrees to move forward with meeting
09/16 ALLERGAN : Botox maker to slash 25 Irish posts
09/16 ALLERGAN : Botox job cuts ; companies today
09/16 ALLERGAN : Pershing Square, Valeant and Allergan Settle Pending Litigation Befor..
09/15 ALLERGAN : to Hold Special Meeting of Stockholders on Originally Scheduled Date ..
09/15 ALLERGAN : Pershing Square Submits Additional Special Meeting Requests
09/15 Ackman's Pershing Square plans $2 billion Amsterdam fund listing
09/12DJU.S. HOT STOCKS : Hot Stocks to Watch
09/12 ALLERGAN : Pershing Square Submits Additional Special Meeting Requests Represent..
09/11 ALLERGAN : Comments on Pershing Square's Delivery of Additional Requests from St..
09/11 ALLERGAN : Comments on Pershing Square's Delivery of Additional Requests from St..
09/11 ALLERGAN : Assigned Patent
09/10 ALLERGAN : Patent Issued for Directionless (Orientation Independent) Needle Inje..
09/10 ALLERGAN : Researchers Submit Patent Application, "Implantable Materials", for A..
09/10 ALLERGAN : Bill Ackman Can Start Writing His Victory Speech (Maybe)
09/10 ALLERGAN : Announces OZURDEX® dexamethasone 700 mcg intravitreal implant in appl..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF